Systemic Sclerosis (Scleroderma) Global Clinical Trials Review, Q2, 2011
NEW YORK, July 5, 2011 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:
Systemic Sclerosis (Scleroderma) Global Clinical Trials Review, Q2, 2011
http://www.reportlinker.com/p0567406/Systemic-Sclerosis-Scleroderma-Global-Clinical-Trials-Review-Q2-2011.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Pathology
Systemic Sclerosis (Scleroderma) Global Clinical Trials Review, Q2, 2011
Summary
GlobalData's clinical trial report, "Systemic Sclerosis (Scleroderma) Global Clinical Trials Review, Q2, 2011" provides data on the Systemic Sclerosis (Scleroderma) clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Systemic Sclerosis (Scleroderma). It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Systemic Sclerosis (Scleroderma). This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Scope
- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)
Reasons to buy
- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 6
Introduction 7
Systemic Sclerosis (Scleroderma) 7
Report Guidance 7
Clinical Trials by Region 8
Clinical Trials by Country 9
Top Countries Contributing to Clinical Trials in Asia-Pacific 11
Top Five Countries Contributing to Clinical Trials in Europe 12
Top Countries Contributing to Clinical Trials in North America 13
Top Countries Contributing to Clinical Trials in Middle East and Africa 14
Top Countries Contributing to Clinical Trials in Central and South America 15
Clinical Trials by BRIC Nations 16
Clinical Trials by Phase 17
In Progress Trials by Phase 18
Clinical Trials by Trial Status 19
Unaccomplished Trials of Systemic Sclerosis (Scleroderma) 20
Subjects Recruited Over a Period of Time 22
Prominent Sponsors 23
Top Companies Participating in Systemic Sclerosis (Scleroderma) Therapeutics Clinical Trials 25
Prominent Drug Comparison 27
Clinical Trial Profiles 28
Clinical Trial Overview of Top Companies 28
United Therapeutics Corporation 28
Clinical Trial Overview of United Therapeutics Corporation 28
Actelion Ltd 29
Clinical Trial Overview of Actelion Ltd 29
MediQuest Therapeutics, Inc. 30
Clinical Trial Overview of MediQuest Therapeutics, Inc. 30
MedImmune, LLC 31
Clinical Trial Overview of MedImmune, LLC 31
Benesis Corporation 32
Clinical Trial Overview of Benesis Corporation 32
Daval International Ltd. 33
Clinical Trial Overview of Daval International Ltd. 33
Amira Pharmaceuticals, Inc. 34
Clinical Trial Overview of Amira Pharmaceuticals, Inc. 34
Active Biotech AB 35
Clinical Trial Overview of Active Biotech AB 35
Novartis AG 36
Clinical Trial Overview of Novartis AG 36
Allergan, Inc. 37
Clinical Trial Overview of Allergan, Inc. 37
Genzyme Corporation 38
Clinical Trial Overview of Genzyme Corporation 38
Bristol-Myers Squibb Company 39
Clinical Trial Overview of Bristol-Myers Squibb Company 39
Clinical Trial Overview of Top Universities / Institutes / Hospitals 40
Fred Hutchinson Cancer Research Center-Technology Transfer 40
Clinical Trial Overview of Fred Hutchinson Cancer Research Center-Technology Transfer 40
Rouen University Hospital 41
Clinical Trial Overview of Rouen University Hospital 41
Johns Hopkins University 42
Clinical Trial Overview of Johns Hopkins University 42
Assistance Publique - Hopitaux de Paris 43
Clinical Trial Overview of Assistance Publique - Hopitaux de Paris 43
Stanford University 44
Clinical Trial Overview of Stanford University 44
University of California, Los Angeles 45
Clinical Trial Overview of University of California, Los Angeles 45
The National Institute of Allergy and Infectious Diseases 46
Clinical Trial Overview of The National Institute of Allergy and Infectious Diseases 46
Hospital for Special Surgery 47
Clinical Trial Overview of Hospital for Special Surgery 47
University of Medicine and Dentistry New Jersey 48
Clinical Trial Overview of University of Medicine and Dentistry New Jersey 48
Duke University 49
Clinical Trial Overview of Duke University 49
Boston University 50
Clinical Trial Overview of Boston University 50
University of Michigan 51
Clinical Trial Overview of University of Michigan 51
Charite University 52
Clinical Trial Overview of Charite University 52
Georgetown University 53
Clinical Trial Overview of Georgetown University 53
Northwestern University 54
Clinical Trial Overview of Northwestern University 54
Universita' Politecnica delle Marche 55
Clinical Trial Overview of Universita' Politecnica delle Marche 55
Alexandria University 56
Clinical Trial Overview of Alexandria University 56
Arthritis Research UK 57
Clinical Trial Overview of Arthritis Research UK 57
Thomas Jefferson University 58
Clinical Trial Overview of Thomas Jefferson University 58
University Hospital, Bordeaux 59
Clinical Trial Overview of University Hospital, Bordeaux 59
Appendix 60
Abbreviations 60
Definitions 60
Research Methodology 61
Secondary Research 61
About GlobalData 62
Contact Us 62
Disclaimer 62
Source 62
List of Tables
Systemic Sclerosis (Scleroderma) Therapeutics Market, Global, Clinical Trials by Zone, 2011* 8
Systemic Sclerosis (Scleroderma) Therapeutics Market, Global, Clinical Trials by Top Countries, 2011* 9
Systemic Sclerosis (Scleroderma) Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2011* 10
Systemic Sclerosis (Scleroderma) Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2011* 11
Systemic Sclerosis (Scleroderma) Therapeutics Clinical Trials, Europe, Top Five Countries, 2011* 12
Systemic Sclerosis (Scleroderma) Therapeutics Clinical Trials, North America, Top Countries, 2011* 13
Systemic Sclerosis (Scleroderma) Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2011* 14
Systemic Sclerosis (Scleroderma) Therapeutics Clinical Trials, Central and South America, Top Countries, 2011* 15
Systemic Sclerosis (Scleroderma) Therapeutics Clinical Trials, BRIC Countries, 2011* 16
Systemic Sclerosis (Scleroderma) Therapeutics Market, Global, Clinical Trials by Phase, 2011* 17
Systemic Sclerosis (Scleroderma) Therapeutics Market, Global, Clinical Trials In Progress by Phase 2011* 18
Systemic Sclerosis (Scleroderma) Therapeutics Market, Global, Clinical Trials by Trial Status, 2011* 19
Systemic Sclerosis (Scleroderma) Therapeutics Market, Global, Withdrawn Clinical Trials, 2011* 20
Systemic Sclerosis (Scleroderma) Therapeutics Market, Global, Terminated Clinical Trials, 2011* 21
Systemic Sclerosis (Scleroderma) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2005-2010 22
Systemic Sclerosis (Scleroderma) Therapeutics Clinical Trials, Global, Key Sponsors, 2011* 24
Systemic Sclerosis (Scleroderma) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2011* 26
Systemic Sclerosis (Scleroderma) Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2011* 27
Systemic Sclerosis (Scleroderma) Therapeutics Clinical Trials Market, Global, Clinical Trials by United Therapeutics Corporation, 2011* 28
Systemic Sclerosis (Scleroderma) Therapeutics Clinical Trials Market, Global, Clinical Trials by Actelion Ltd, 2011* 29
Systemic Sclerosis (Scleroderma) Therapeutics Clinical Trials Market, Global, Clinical Trials by MediQuest Therapeutics, Inc., 2011* 30
Systemic Sclerosis (Scleroderma) Therapeutics Clinical Trials Market, Global, Clinical Trials by MedImmune, LLC, 2011* 31
Systemic Sclerosis (Scleroderma) Therapeutics Clinical Trials Market, Global, Clinical Trials by Benesis Corporation, 2011* 32
Systemic Sclerosis (Scleroderma) Therapeutics Clinical Trials Market, Global, Clinical Trials by Daval International Ltd., 2011* 33
Systemic Sclerosis (Scleroderma) Therapeutics Clinical Trials Market, Global, Clinical Trials by Amira Pharmaceuticals, Inc., 2011* 34
Systemic Sclerosis (Scleroderma) Therapeutics Clinical Trials Market, Global, Clinical Trials by Active Biotech AB, 2011* 35
Systemic Sclerosis (Scleroderma) Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2011* 36
Systemic Sclerosis (Scleroderma) Therapeutics Clinical Trials Market, Global, Clinical Trials by Allergan, Inc., 2011* 37
Systemic Sclerosis (Scleroderma) Therapeutics Clinical Trials Market, Global, Clinical Trials by Genzyme Corporation, 2011* 38
Systemic Sclerosis (Scleroderma) Therapeutics Clinical Trials Market, Global, Clinical Trials by Bristol-Myers Squibb Company, 2011* 39
Systemic Sclerosis (Scleroderma) Therapeutics Clinical Trials Market, Global, Clinical Trials by Fred Hutchinson Cancer Research Center-Technology Transfer, 2011* 40
Systemic Sclerosis (Scleroderma) Therapeutics Clinical Trials Market, Global, Clinical Trials by Rouen University Hospital, 2011* 41
Systemic Sclerosis (Scleroderma) Therapeutics Clinical Trials Market, Global, Clinical Trials by Johns Hopkins University, 2011* 42
Systemic Sclerosis (Scleroderma) Therapeutics Clinical Trials Market, Global, Clinical Trials by Assistance Publique - Hopitaux de Paris, 2011* 43
Systemic Sclerosis (Scleroderma) Therapeutics Clinical Trials Market, Global, Clinical Trials by Stanford University, 2011* 44
Systemic Sclerosis (Scleroderma) Therapeutics Clinical Trials Market, Global, Clinical Trials by University of California, Los Angeles, 2011* 45
Systemic Sclerosis (Scleroderma) Therapeutics Clinical Trials Market, Global, Clinical Trials by The National Institute of Allergy and Infectious Diseases, 2011* 46
Systemic Sclerosis (Scleroderma) Therapeutics Clinical Trials Market, Global, Clinical Trials by Hospital for Special Surgery, 2011* 47
Systemic Sclerosis (Scleroderma) Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Medicine and Dentistry New Jersey, 2011* 48
Systemic Sclerosis (Scleroderma) Therapeutics Clinical Trials Market, Global, Clinical Trials by Duke University, 2011* 49
Systemic Sclerosis (Scleroderma) Therapeutics Clinical Trials Market, Global, Clinical Trials by Boston University, 2011* 50
Systemic Sclerosis (Scleroderma) Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Michigan, 2011* 51
Systemic Sclerosis (Scleroderma) Therapeutics Clinical Trials Market, Global, Clinical Trials by Charite University, 2011* 52
Systemic Sclerosis (Scleroderma) Therapeutics Clinical Trials Market, Global, Clinical Trials by Georgetown University, 2011* 53
Systemic Sclerosis (Scleroderma) Therapeutics Clinical Trials Market, Global, Clinical Trials by Northwestern University, 2011* 54
Systemic Sclerosis (Scleroderma) Therapeutics Clinical Trials Market, Global, Clinical Trials by Universita' Politecnica delle Marche, 2011* 55
Systemic Sclerosis (Scleroderma) Therapeutics Clinical Trials Market, Global, Clinical Trials by Alexandria University, 2011* 56
Systemic Sclerosis (Scleroderma) Therapeutics Clinical Trials Market, Global, Clinical Trials by Arthritis Research UK, 2011* 57
Systemic Sclerosis (Scleroderma) Therapeutics Clinical Trials Market, Global, Clinical Trials by Thomas Jefferson University, 2011* 58
Systemic Sclerosis (Scleroderma) Therapeutics Clinical Trials Market, Global, Clinical Trials by University Hospital, Bordeaux, 2011* 59
List of Figures
Systemic Sclerosis (Scleroderma) Therapeutics Market, Global, Clinical Trials by Zone (%), 2011* 8
Systemic Sclerosis (Scleroderma) Therapeutics Market, Global, Clinical Trials by Top Countries, 2011* 9
Systemic Sclerosis (Scleroderma) Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2011* 10
Systemic Sclerosis (Scleroderma) Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2011* 11
Systemic Sclerosis (Scleroderma) Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2011* 12
Systemic Sclerosis (Scleroderma) Therapeutics Clinical Trials, North America, Top Countries (%), 2011* 13
Systemic Sclerosis (Scleroderma) Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2011* 14
Systemic Sclerosis (Scleroderma) Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2011* 15
Systemic Sclerosis (Scleroderma) Therapeutics Clinical Trials, BRIC Countries (%), 2011* 16
Systemic Sclerosis (Scleroderma) Therapeutics Market, Global, Clinical Trials by Phase (%), 2011* 17
Systemic Sclerosis (Scleroderma) Therapeutics Market, Global, Clinical Trials In Progress by Phase, 2011* 18
Systemic Sclerosis (Scleroderma) Therapeutics Market, Global, Clinical Trials by Trial Status, 2011* 19
Systemic Sclerosis (Scleroderma) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2005-2010 22
Systemic Sclerosis (Scleroderma) Therapeutics Clinical Trials, Global, Key Sponsors, 2011* 23
Systemic Sclerosis (Scleroderma) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2011* 25
Systemic Sclerosis (Scleroderma) Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2011* 27
GlobalData Methodology 61
Companies Mentioned
To order this report:
Pathology Industry: Systemic Sclerosis (Scleroderma) Global Clinical Trials Review, Q2, 2011
Pathology Business News
Check our Company Profile, SWOT and Revenue Analysis!
Nicolas Bombourg
Reportlinker
Email: [email protected]
US: (805)652-2626
Intl: +1 805-652-2626
SOURCE Reportlinker
Share this article